Physician Profile

Anna Ferrari, MD
Director, Genitourinary Oncology Program
Medical Oncologist

I am a medical oncologist and clinical researcher dedicated to prostate cancer research. My experience includes clinical practice and basic laboratory science investigations geared towards preclinical testing for clinical trial development in Prostate Cancer. I joined Rutgers Cancer Institute of New Jersey as the Director of the Genitourinary (GU) Cancer Program and Professor of Medicine. I previously served as Co-Director of Genitourinary (GU) Program for NYU Perlmutter Cancer Center. Prior to that, I spent several years at Mount Sinai School of Medicine, serving as Director of the Genitourinary Cancer Program.   

As a member of the Genitourinary Committee and Prostate Cancer Clinical Trials Consortium, I help develop clinical trials for prostate cancer on a national level. For many years I played a major role in the clinical trials that lead to the approval of Provenge®, the first FDA approved vaccine for treatment of prostate cancer. I am also currently active in the development of new agents and vaccines that are highly promising for prostate cancer patients.

As part of the collaborate care offered at Rutgers Cancer Institute of New Jersey, I work with multi-discipline experts in the Prostate Cancer and Urology Oncology Programs, which include radiation and surgical oncologists, nurses and social workers. I provide patients with a comprehensive evaluation, educating them about their disease and treatment options so they can make informed decisions about their care.  Additionally, I am a strong supporter of patient support groups and I lecture regularly to help men understand the prostate cancer spectrum of treatment options and choices.

Clinical Expertise 

Prostate cancer, vaccines, clinical trials

Contact Information  

To schedule a new patient appointment call 732-235-8515.
For all other inquiries call 732-235-2465.


precision medicine at Rutgers Cancer Institute







Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health